Spontaneous Resolution of Calvarial Eosinophilic Granuloma in ChildrenOliveira M.a,c · Steinbok P.a,c · Wu J.b,d · Heran N.a,c · Cochrane D.a,c
Divisions of aPediatric Neurosurgery and bOncology, British Columbia’s Children’s Hospital, Children and Women’s Health Centre, Departments of cSurgery and dPediatrics, University of British Columbia, Vancouver, B.C., Canada
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Objective: The recommended treatment for solitary calvarial eosinophilic granuloma (EG) is surgical resection by curettage, craniectomy or craniotomy. The purpose of this study was to describe the spontaneous resolution of calvarial EG and discuss ‘observation only’ as an option in the management of this condition. Methods: A retrospective review was performed of children with calvarial EG seen at a tertiary care children’s hospital. Of a total of 17 such patients, four were managed without any intervention and formed the basis of this report. Results: In all four patients treated by ‘observation only’, there was a tender calvarial mass which enlarged rapidly over a few days and then resolved slowly over many weeks. The diagnosis of EG was based on the findings of plain radiographs and/or computed tomography. All masses had resolved by 8 weeks, and the underlying cranial defect filled in spontaneously in all cases. There was no recurrence at follow-up, which ranged from 2 months to 7 years. Conclusions: ‘Observation only’ should be considered as a viable option in the management of children with solitary calvarial masses that have the radiographic features of EG. Consideration should be given to delaying surgical intervention to allow time to see if spontaneous resolution occurs.
© 2003 S. Karger AG, Basel
- Rawlings CE 3rd, Wilkins RH: Solitary eosinophilic granuloma of the skull. Neurosurgery 1984;15:155–161.
- Slater JM, Swarm OJ: Eosinophilic granuloma of bone. Med Pediatr Oncol 1980;8:151–164.
- Arseni C, Danaila L, Constantinescu A: Cranial eosinophilic granuloma. Neurochirurgia (Stuttg) 1977;20:189–199.
- Manaka S, Izawa M, Nawata H: Skull tumor simulating sinus pericranii. Case report. J Neurosurg 1977;46:671–673.
- Feldman RB, Moore DM, Hood CI, Hiles DA, Romano PE: Solitary eosinophilic granuloma of the lateral orbital wall. Am J Ophthalmol 1985;100:318–323.
- Shelby JH, Sweet RM: Eosinophilic granuloma of the temporal bone: Medical and surgical management in the pediatric patient. South Med J 1983;76:65–70.
- Appling D, Jenkins HA, Patton GA: Eosinophilic granuloma in the temporal bone and skull. Otolaryngol Head Neck Surg 1983;91:358–365.
- Martinez-Lage JF, Poza M, Cartagena J, Vicente JP, Biec F, de las Heras M: Solitary eosinophilic granuloma of the pediatric skull and spine. The role of surgery. Childs Nerv Syst 1991;7:448–451.
- Mitnick JS, Pinto RS: Computed tomography in the diagnosis of eosinophilic granuloma. J Comput Assist Tomogr 1980;4:791–793.
- Hadjigeorgi C, Parpounas C, Zarmakoupis P, Lafoyianni S: Eosinophilic granuloma of the temporal bone: Radiological approach in the pediatric patient. Pediatr Radiol 1990;20:546–549.
- Hermans R, De Foer B, Smet MH, Leysen J, Feenstra L, Fossion E, Baert AL: Eosinophilic granuloma of the head and neck: CT and MRI features in three cases. Pediatr Radiol 1994;24:33–36.
- David R, Oria RA, Kumar R, Singleton EB, Lindell MM, Shirkhoda A, Madewell JE: Radiologic features of eosinophilic granuloma of bone. AJR Am J Roentgenol 1989;153:1021–1026.
- Yanagawa T, Watanabe H, Shinozaki T, Ahmed AR, Shirakura K, Takagishi K: The natural history of disappearing bone tumours and tumour-like conditions. Clin Radiol 2001;56:877–886.
- Hefti F, Jundt G: Langerhans cell histiocytosis (in German). Orthopäde 1995;24:73–81.
Kamimura M, Kinoshita T, Itoh H, Yuzawa Y, Takahashi J, Ohtsuka K: Eosinophilic granuloma of the spine: Early spontaneous disappearance of tumor detected on magnetic resonance imaging. Case report. J Neurosurg 2000;93(2 suppl):312–316.
- Schmitz L, Favara BE: Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:221–246.
- Herzog KM, Tubbs RR: Langerhans cell histiocytosis. Adv Anat Pathol 1998;5:347–358.
- Lavin PT, Osband ME: Evaluating the role of therapy in histiocytosis-X. Clinical studies, staging, and scoring. Hematol Oncol Clin North Am 1987;1:35–47.
- Leikin SL: Immunobiology of histiocytosis-X. Hematol Oncol Clin North Am 1987;1:49–61.
- Alvarez-Sala R, Prados C, de Miguel E, Garcia-Talavera I, Munoz J: Histiocytosis X and ankylosing spondylitis. A common pathogenesis? (in Spanish). An Med Interna 1996;13:339–340.
- Zeff RA, Freitag A, Grin CM, Grant-Kels JM: The immune response in halo nevi. J Am Acad Dermatol 1997;37:620–624.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.